Who
Jennifer R. Cochran
Director
Company insider
Files Form 4 as: Director, OmniAb; Director and Other, Ligand Pharmaceuticals.
In numbers
- Trades disclosed
- 37
- Buys
- 3
- Sells
- 0
- Bought
- $222K
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 12 Jul 2021
- Last trade
- 17 Jun 2026
- Last filed
- 18 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 17 Jun 2026filed 18 Jun 2026 | OABI OmniAbLife-science tools | SEC FORM 4 Code M | —20,000 | filing |
| 17 Jun 2026filed 18 Jun 2026 | OABI OmniAboption or derivative · Life-science tools | SEC FORM 4 Code M | —20,000 at $0.00 | filing |
| 17 Jun 2026filed 18 Jun 2026 | OABI OmniAboption or derivative · Life-science tools | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 17 Jun 2026filed 18 Jun 2026 | OABI OmniAboption or derivative · Life-science tools | SEC FORM 4 Code M | —20,000 at $0.00 | filing |
| 17 Jun 2026filed 18 Jun 2026 | OABI OmniAboption or derivative · Life-science tools | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 17 Jun 2026filed 18 Jun 2026 | OABI OmniAboption or derivative · Life-science tools | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 17 Jun 2026filed 18 Jun 2026 | OABI OmniAboption or derivative · Life-science tools | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 17 Jun 2026filed 18 Jun 2026 | OABI OmniAbLife-science tools | SEC FORM 4 Code M | —20,000 | filing |
| 17 Jun 2025filed 18 Jun 2025 | OABI OmniAboption or derivative · Life-science tools | SEC FORM 4 Code M | —20,000 at $0.00 | filing |
| 17 Jun 2025filed 18 Jun 2025 | OABI OmniAboption or derivative · Life-science tools | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 17 Jun 2025filed 18 Jun 2025 | OABI OmniAboption or derivative · Life-science tools | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 17 Jun 2025filed 18 Jun 2025 | OABI OmniAbLife-science tools | SEC FORM 4 Code M | —20,000 | filing |
| 15 May 2025filed 15 May 2025 | OABI OmniAbLife-science tools | SEC FORM 4 Bought | $46K30,000 at $1.52 | filing |
| 12 Jul 2024filed 12 Jul 2024 | OABI OmniAboption or derivative · Life-science tools | SEC FORM 4 Code M | —1,896 at $0.00 | filing |
| 12 Jul 2024filed 12 Jul 2024 | OABI OmniAbLife-science tools | SEC FORM 4 Code M | —1,896 | filing |
| 18 Jun 2024filed 21 Jun 2024 | OABI OmniAboption or derivative · Life-science tools | SEC FORM 4 Code M | —20,000 at $0.00 | filing |
| 18 Jun 2024filed 21 Jun 2024 | OABI OmniAboption or derivative · Life-science tools | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 18 Jun 2024filed 21 Jun 2024 | OABI OmniAboption or derivative · Life-science tools | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 18 Jun 2024filed 21 Jun 2024 | OABI OmniAbLife-science tools | SEC FORM 4 Code M | —20,000 | filing |
| 12 Jul 2023filed 14 Jul 2023 | OABI OmniAboption or derivative · Life-science tools | SEC FORM 4 Code M | —1,896 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.